Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin

References

• HerszényiLTulassayZEpidemiology of gastrointestinal and liver tumorsEur Rev Med Pharmacol Sci201014424925820496531
   PubMed Web of Science ®Google Scholar
• Ministry of Health and WelfareCause of Death Statistics2013 Available from: http://www.mohw.gov.tw/EN/Ministry/Statistic.aspx?f_list_no=474&fod_list_no=5044Accessed January 19, 2015
   Google Scholar
• WHOGuidelines for the Screening, Care and Treatment of Persons with Hepatitis C InfectionGeneva, SwitzerlandWHO2014
   Google Scholar
• El-SeragHBHepatocellular carcinomaN Engl J Med2011365121118112721992124
   PubMed Web of Science ®Google Scholar
• ReinDBWittenbornJSWeinbaumCMSabinMSmithBDLesesneSBForecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United StatesDig Liver Dis2011431667220739252
   PubMedGoogle Scholar
• PearlmanBLTraubNSustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much moreClin Infect Dis201152788990021427396
   PubMed Web of Science ®Google Scholar
• VeldtBJHeathcoteEJWedemeyerHSustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosisAnn Intern Med20071471067768418025443
   PubMed Web of Science ®Google Scholar
• BrunoSBattezzatiPMBellatiGLong-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis CJ Hepatol200134574875511434622
   PubMed Web of Science ®Google Scholar
• MorganRLBaackBSmithBDYartelAPitasiMFalck-YtterYEradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studiesAnn Intern Med20131585 Pt 132933723460056
   PubMed Web of Science ®Google Scholar
• HungCHLeeCMWangJHImpact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapyInt J Cancer2011128102344235220669224
   PubMed Web of Science ®Google Scholar
• Asia-Pacific Working Party on Prevention of Hepatocellular CarcinomaPrevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statementsJ Gastroenterol Hepatol201025465766320492323
   PubMed Web of Science ®Google Scholar
• WaiCTGreensonJKFontanaRJA simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CHepatology200338251852612883497
   PubMed Web of Science ®Google Scholar
• Vallet-PichardAMalletVNalpasBFIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotestHepatology2007461323617567829
   PubMed Web of Science ®Google Scholar
• VergniolJBoursierJCoutzacCEvolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis CHepatology2014601657624519328
   PubMed Web of Science ®Google Scholar
• YuMLLinSMLeeCMA simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapyHepatology20064451086109717058238
   PubMed Web of Science ®Google Scholar
• HannHWWanSLaiYAspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infectionJ Gastroenterol Hepatol201530113113824995497
   PubMed Web of Science ®Google Scholar
• WuCKChangKCHungCHDynamic alpha-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapyJ Antimicrob Chemother20167171943194727073265
   PubMed Web of Science ®Google Scholar
• LeeKSinnDHGwakGYPrediction of the risk of hepatocellular carcinoma in chronic hepatitis C patients after sustained virological response by aspartate aminotransferase to platelet ratio indexGut Liver Epub2016428
   Web of Science ®Google Scholar
• ChungHAKimJHHwangYNoninvasive fibrosis marker can predict recurrence of hepatocellular carcinoma after radiofrequency ablationSaudi J Gastroenterol2016221576326831608
   PubMed Web of Science ®Google Scholar
• FriedMWSide effects of therapy of hepatitis C and their managementHepatology2002365 Suppl 1S237S24412407599
   PubMed Web of Science ®Google Scholar
• OmataMKandaTYuMLAPASL consensus statements and management algorithms for hepatitis C virus infectionHepatol Int20126240943526201405
   PubMed Web of Science ®Google Scholar
• European Association for Study of LiverEASL Clinical Practice Guidelines: management of hepatitis C virus infectionJ Hepatol201460239242024331294
   PubMed Web of Science ®Google Scholar
• HuangJFYuMLLeeCMSustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from TaiwanAliment Pharmacol Ther20072591029103717439503
   PubMed Web of Science ®Google Scholar
• BruixJShermanMAmerican Association for the Study of Liver DiseasesManagement of hepatocellular carcinoma: an updateHepatology20115331020102221374666
   PubMed Web of Science ®Google Scholar
• de LopeCRTremosiniSFornerAReigMBruixJManagement of HCCJ Hepatol201256Suppl 1S75S8722300468
   PubMed Web of Science ®Google Scholar
• RatgeDScheiblhuberBNitscheMKnabbeCHigh-speed detection of blood-borne hepatitis C virus RNA by single-tube real-time fluorescence reverse transcription-PCR with the LightCyclerClin Chem200046121987198911106331
   PubMed Web of Science ®Google Scholar
• BullockGCBrunsDEHaverstickDMHepatitis C genotype determination by melting curve analysis with a single set of fluorescence resonance energy transfer probesClin Chem200248122147215412446470
   PubMed Web of Science ®Google Scholar
• SelimovicDEl-KhattoutiAGhozlanHHaikelYAbdelkaderOHassanMHepatitis C virus-related hepatocellular carcinoma: an insight into molecular mechanisms and therapeutic strategiesWorld J Hepatol201241234235523355912
   PubMedGoogle Scholar
• FabregatIDysregulation of apoptosis in hepatocellular carcinoma cellsWorld J Gastroenterol200915551352019195051
   PubMed Web of Science ®Google Scholar
• ButDYLaiCLYuenMFNatural history of hepatitis-related hepatocellular carcinomaWorld J Gastroenterol200814111652165618350595
   PubMed Web of Science ®Google Scholar
• SewellJLStickKMMontoAHepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsyEur J Gastroenterol Hepatol200921222522919212213
   PubMed Web of Science ®Google Scholar
• MasuzakiRYoshidaHOmataMInterferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis/liver cirrhosisOncology201078Suppl 1172320616579
   PubMed Web of Science ®Google Scholar
• CammàCGiuntaMAndreonePCraxìAInterferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approachJ Hepatol200134459360211394661
   PubMed Web of Science ®Google Scholar
• OkudaHHepatocellular carcinoma development in cirrhosisBest Pract Res Clin Gastroenterol200721116117317223503
   PubMed Web of Science ®Google Scholar
• BruixJShermanMPractice Guidelines Committee American Association for the Study of Liver DiseasesManagement of hepatocellular carcinomaHepatology20054251208123616250051
   PubMed Web of Science ®Google Scholar
• HuangCFYehMLTsaiPCBaseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradicationJ Hepatol2014611677424613362
   PubMed Web of Science ®Google Scholar